肝癌和乙型肝炎病毒感染的关系研究进展.pdf

医学综述2002年第8卷第9期 MedicalRecapitulate2002,Vol.8,No.9 551 insights[J].ClinMicrobialRev,1995,8(6):496-514 [12]KellyBP,ForneySK,JessenMT,etal.Low-doseaerosolinfection genet KapurV,LiL,IordaneseuS,etal.CharacterizationbyautomatedDNA modelfortestingdrugsforefficacyagainstMycobacteriumtuberculosis sequencingofmutationsinthegene(rpoB)encodingtheRNAPsubunit [J].AntimicrobAgentsChemother,1996,40(12):2809. inrifampinresistantMycobacteriumtuberculosisstainsfromNewYork [13] KennedyN,FoxR,UisoL,etal.Safetyprofileofciprofloxacinduring CityandTexas[J]JClinMicrobio1,1994,32(4):1095-1098. long-termtherapyforpulmonarytuberculosis[J].JAntimicrobChe- MorrsS,BaiGH,SuffysP,etal.Molecularmechanismsofmultiple- mother,1993,32(6):897-902. druyresistantceinclinicalisolatesofMycobacteriumtuberculosis[J]. [14〕何国均.抗结核药物的研究进展 J「].中国防疥杂志，1995,18 JID,1995,171(3):954-960. (3):137. SreevatsanS,PanX,StockbauerKS,etal.CharacterizationofrpsLand 1〔5] HerbertD,ParamasivanCN,VenkatesanP,etal.Bactericidalactionof rrsmutationsinstreptomycin-resistantMycobacteriumtuberculosisiso- ofloxacin,salbactamampicillin,rifampin,andisoniazidonlogarithmic latesfromdiversegeographiclocalities[J].AntimicrobAgentsChe- andstationary-phaseculturesofMycobacteriumtuberculosis[J了.Anti- mother,1996,40(4):1024-1026. microbAgentsChemother,1996,40(10):2296-2299. FinkenM,KirschnerP,MeierA,etal.Molecularbasisofstreptomycin [16]WorldHealthOrganization.WHOtuberculosisreseachanddevelopment resistanceinMycobacteriumtuberculosis:alterationsoftheribosomal [R].Geneva:WHO,1991. S12geneandpointmutationswithinafunctional16SribosomalRNA [17」 吕福祯，邵宝新，阎迎春，等.乌体林斯加抗结核药对耐多药肺 pseudoknot[J].MolMicrobiol,1993,9(6):1239. [ l 0 : 结核疗效分析 C〔].中华医学会全国多耐药结核病学术会议论 SreevatsanS,PanX,ZhangY,etal.M